Therapeutic Drug Monotoring: CYP2C19 genetic polymorphism and major depression

被引:0
|
作者
Adamovic, I [1 ]
Michaelis, S. [1 ]
Streit, F. [1 ]
Binder, L. [1 ]
Degner, D. [1 ]
机构
[1] Univ Gottingen, Gottingen, Germany
关键词
D O I
10.1055/s-0039-3403049
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P7.4
引用
收藏
页码:98 / 98
页数:1
相关论文
共 50 条
  • [31] Genetic polymorphism of CYP2C19 and subcortical variability in the human adult brain
    Julia C. Stingl
    Catharina Scholl
    Julia E. Bosch
    Roberto Viviani
    Translational Psychiatry, 11
  • [32] Genetic Polymorphism of CYP2C19 Is Associated with the Susceptibility to Bile Duct Cancer
    Isomura, Yoshihiro
    Yamaji, Yutaka
    Ohta, Miki
    Takano, Noriyuki
    Kajiwara, Haruka
    Yoshida, Shuntaro
    Yamada, Atsuo
    Sugimoto, Takafumi
    Ogura, Keiji
    Kawabe, Takao
    Omata, Masao
    GASTROENTEROLOGY, 2009, 136 (05) : A480 - A480
  • [33] Effects of Omeprazole and Genetic Polymorphism of CYP2C19 on the Clopidogrel Active Metabolite
    Boulenc, Xavier
    Djebli, Nassim
    Shi, Juan
    Perrin, Laurent
    Brian, William
    Van Horn, Robert
    Hurbin, Fabrice
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (01) : 187 - 197
  • [34] Genetic Polymorphism Analysis of CYP2C19 in the Han nationality with CAD in Beijing
    Yang, Shengli
    Sun, Yaqin
    Wang, Liang
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C267 - C267
  • [35] A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer
    Yoshihiro Isomura
    Yutaka Yamaji
    Miki Ohta
    Motoko Seto
    Yoshinari Asaoka
    Yasuo Tanaka
    Takashi Sasaki
    Yousuke Nakai
    Naoki Sasahira
    Hiroyuki Isayama
    Minoru Tada
    Haruhiko Yoshida
    Takao Kawabe
    Masao Omata
    Kazuhiko Koike
    Journal of Gastroenterology, 2010, 45 : 1045 - 1052
  • [36] Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro:: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism
    Shon, JH
    Yoon, YR
    Kim, MJ
    Kim, KA
    Lim, YC
    Liu, KH
    Shin, DH
    Lee, CH
    Cha, IJ
    Shin, JG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 552 - 563
  • [37] Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study
    Heydy V. Bravo-Villalta
    Koujirou Yamamoto
    Katsunori Nakamura
    Ana Bayá
    Yuko Okada
    Ryuya Horiuchi
    European Journal of Clinical Pharmacology, 2005, 61 : 179 - 184
  • [38] CYP2C19 Genetic Variants and Major Depressive Disorder: A Systematic Review
    Bonasser, Larissa Sousa Silva
    Silva, Calliandra Maria de Souza
    Fratelli, Caroline Ferreira
    Gontijo, Bruna Rodrigues
    Seixas, Juliana Moura Alves
    Barreto, Livia Cristina Lira de Sa
    da Silva, Izabel Cristina Rodrigues
    PHARMACEUTICALS, 2024, 17 (11)
  • [39] Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population:: an investigative and comparative study
    Bravo-Villalta, HV
    Yamamoto, K
    Nakamura, K
    Bayá, A
    Okada, Y
    Horiuchi, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (03) : 179 - 184
  • [40] CYP2C19 polymorphism increases the risk of endometriosis
    Christofolini, Denise Maria
    Amaro, Aline
    Mafra, Fernanda
    Sonnewend, Amanda
    Bianco, Bianca
    Barbosa, Caio Parente
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2015, 32 (01) : 91 - 94